Capstone Therapeutics Cor... (CAPS)
NASDAQ: CAPS
· Real-Time Price · USD
1.01
-0.01 (-0.98%)
At close: Aug 21, 2025, 3:58 PM
1.01
0.00%
After-hours: Aug 21, 2025, 07:38 PM EDT
Capstone Therapeutics Revenue
Capstone Therapeutics reported an annual revenue of $44.88M, reflecting a -7.19% growth. For the quarter ending June 30, 2025, Capstone Therapeutics generated $12.85M in revenue.
Revenue (ttm)
44.88M
Revenue Growth
-7.19%
Price / Sales Ratio
0.01
Revenue / Employee
1.25M
Employees
36
Market Cap
5.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 44.88M | -7.19% |
| Dec 31, 2023 | 48.35M | -21.45% |
| Dec 31, 2022 | 61.56M | -7.76% |
| Dec 31, 2021 | 66.74M | +46.85% |
| Dec 31, 2020 | 45.45M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |